GlassScriptPhysician profile
Eugene K Lee
NPI 1033230933
$1,328.28
in general payments reported to CMS, 2019-2025
21 companies · $427 in 2025
The $427 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.00 · 2020: $34.44 · 2021: $169 · 2022: $84.49 · 2023: $239 · 2024: $298 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $799.02 |
| Education | $164.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $296.82 | 2021-2024 | |
| Histosonics, INC. | $232.30 | 2025 | |
| Astellas Pharma US INC | $186.14 | 2019-2023 | |
| Urogen Pharma, INC. | $93.73 | 2024-2025 | |
| Jazz Pharmaceuticals INC. | $91.96 | 2024 | |
| Janssen Biotech, INC. | $70.15 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $69.63 | 2021-2025 | Ams 700 |
| Janssen Scientific Affairs, LLC | $64.49 | 2022-2024 | Erleada, Balversa, Pipeline |
| 180 Medical, INC. | $49.19 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $47.36 | 2025 | Provenge |
| Convatec INC. | $34.09 | 2019-2023 | |
| Endo USA, INC. | $24.71 | 2025 | Xiaflex |
| Merck Sharp & Dohme LLC | $21.72 | 2022 | |
| Calyxo, INC. | $17.79 | 2025 | Cvac Aspiration System |
| Abbvie INC. | $14.27 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $13.93 | 2020 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.